Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
At a glance
Social responsibility
Our companies
Business Model
Development capabilites
Partnering
Pipeline
Commercial Products
News & Events
Press Releases
Awards
Publications
Conferences
News
27.04.2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
26.04.2010
Two New Tenants for EPFL’s Innovation Square
Home
News & Events
Publications
Debio 0719
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
23-Feb-2009
Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist
15-Aug-2008
Cross-talk between LPA1 and Epidermal Growth Factor Receptors Mediates Up-regulation of Sphingosine Kinase 1 to Promote Gastric Cancer Cell Motility and Invasion
20-Jun-2006
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
23-Apr-2004
Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and non-neoplastic cells through LPA
20-Feb-2004
Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA
16-Jul-2003
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors
< Prev
1
Next >
Results 1 - 6 of 6
Debio 025
( 37 items )
Triptorelin / Decapeptyl / Trelstar
( 7 items )
Oxaliplatin – Eloxatin – Elplat
( 12 items )
Debio 0614
( 3 items )
Debio 9902 - ZT-1
( 8 items )
Debio 8609 Sanvar
( 1 items )
Archives
( 15 items )